21/05/2026
|
Dr. Elisa Motori, principal investigator at the Center for Molecular Medicine Cologne (CMMC) and the CECAD Research Center, has been awarded funding through the prestigious Plus 3 program of the Boehringer Ingelheim Foundation.
19/05/2026
|
Researchers from the CECAD Cluster of Excellence for Aging Research and Center for Molecular Medicine Cologne (CMMC) found that the lipid known as cardiolipin is crucial for keeping the immune response in the gut under control.
18/05/2026
|
The Collaborative Research Center (SFB) 1530 on the research and treatment of B-cell neoplasms will receive 10.3 million euros in funding from the German Research Foundation (DFG) for another three and a half years.
06/05/2026
|
Experts from University Hospital Cologne and the Faculty of Medicine at the University of Cologne are coordinating a new research project aimed at making the reporting of cancer cases to the North Rhine-Westphalia State Cancer Registry significantly more efficient.
24/04/2026
|
Researchers have discovered that a key protein, cFLIP, is essential for regulating programmed cell death in lymphoma cells. This discovery provides insights into the mechanisms of this cancer’s cell death evasion and could open up new therapeutic routes for patients who do not respond to therapies.